Catalyst Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $706K | Sell |
1,741
-181
| -9% | -$73.4K | 0.08% | 126 |
|
|
2025
Q1 | $956K | Buy |
1,922
+72
| +4% | +$35.8K | 0.18% | 66 |
|
|
2024
Q4 | $962K | Sell |
1,850
-61
| -3% | -$31.7K | 0.18% | 67 |
|
|
2024
Q3 | $1.18M | Sell |
1,911
-3
| -0.2% | -$1.86K | 0.23% | 55 |
|
|
2024
Q2 | $1.06M | Buy |
1,914
+116
| +6% | +$64.1K | 0.23% | 56 |
|
|
2024
Q1 | $984K | Buy |
1,798
+167
| +10% | +$91.4K | 0.25% | 48 |
|
|
2023
Q4 | $866K | Buy |
1,631
+110
| +7% | +$58.4K | 0.24% | 56 |
|
|
2023
Q3 | $770K | Buy |
1,521
+659
| +76% | +$334K | 0.25% | 61 |
|
|
2023
Q2 | $450K | Buy |
862
+72
| +9% | +$37.6K | 0.16% | 93 |
|
|
2023
Q1 | $455K | Buy |
790
+84
| +12% | +$48.4K | 0.2% | 76 |
|
|
2022
Q4 | $389K | Buy |
+706
| New | +$389K | 0.2% | 78 |
|